BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 11.08.2004

Change of Names and Addresses; Technical Amendment

The Food and Drug Administration (FDA) is amending its regulations to reflect name and address changes for the Office of Compliance, Center for Drug Evaluation and Research (CDER). This action is editorial in nature and is intended to provide accuracy and clarity to the agency's regulations.

Source: Federal Register — Food and Drug AdministrationOpen original release →